31st Jul 2008 13:12
Ark Therapeutics Group plc
31 July 2008
Notification of Major Interests in Shares
1 Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
ARK THERAPEUTICS GROUP PLC
2. Reason for the notification (please tick the appropriate box or boxes): N/A
|
An acquisition or disposal of voting rights: |
(x) |
An acquisition or disposal of financial instruments which may
result in the acquisition of shares already issued to which voting
|
rights are attached |
( ) |
|
An event changing the breakdown of voting rights: |
( ) |
|
Other |
( ) |
3. Full name of person(s) subject to the notification obligation:
Aberforth Partners LLP
4. Full name of shareholder(s) (if different from 3):
|
Shareholder |
Shares
|
|
1. Aberforth Smaller Companies Trust plc |
12,621,300 |
|
2. Aberforth UK Small Companies Fund |
8,268,000 |
|
3. The Church Commissioners for England |
1,868,000 |
1, 2 = registered in the name of Nortrust Nominees Ltd A/c Aberfrth
3 = The Church Commissioners for England (Chase GIS) Nominees Ltd
5. Date of the transaction and date on which the threshold is crossed or reached if different:
30/07/2008
6. Date on which issuer notified:
31/07/2008
7. Threshold(s) that is/are crossed or reached:
11%
8. Notified details:
A: Voting rights attached to shares
|
Class/type of shares: |
Ordinary |
|
|
GB0034251727 |
|
Situation previous to the triggering transaction: |
|
Number of shares: |
20,822,415 |
|
Number of voting rights: |
20,822,415 |
Resulting situation after the triggering transaction:
|
Number of shares: |
22,757,300 |
|
Number of voting rights: |
|
Direct: |
N/A |
|
Indirect: |
22,757,300 |
|
% of voting rights: |
|
Direct: |
N/A |
|
Indirect: |
11.09% |
|
B: |
Financial Instruments: |
|
Resulting situation after the triggering transaction: |
|
Type of financial instrument: |
N/A |
|
Expiration date: |
N/A |
|
Exercise/conversion period/date: |
N/A |
|
Number of voting rights that may be acquired |
N/A |
|
|
if the instrument is exercised/ converted: |
|
% of voting rights: |
N/A |
Total (A+B):
|
Number of voting rights: |
22,757,300 |
|
% of voting rights: |
11.09% |
Proxy Voting:
10. Name of the proxy holder:
N/A
11. Number of voting rights proxy holder will cease to hold:
N/A
12. Date on which proxy holder will cease to hold voting rights:
N/A
13. Additional information:
N/A
14. Contact name:
Pauline Robson, Aberforth Partners LLP
15. Contact telephone number:
0131 220 0733
16. Contact name and telephone at issuer:
MARTYN WILLIAMS
Company Secretary
Ark Therapeutics Group plc
020 7388 7722
Related Shares:
PVG.L